Document is current
Any future updates will be listed below
-
Authors
Yang, Huazhen
Yang, Lei https://orcid.org/0000-0003-0232-7915
Chen, Wenwen
Zeng, Yu
Zhang, Yanan
Tang, Yuling
Zeng, Huolin
Yang, Di
Qu, Yuanyuan
Hu, Yao
Liu, Di
Song, Jie
Fang, Fang https://orcid.org/0000-0002-3310-6456
Valdimarsdóttir, Unnur A. https://orcid.org/0000-0001-5382-946X
Li, Qian https://orcid.org/0009-0000-4732-6233
Song, Huan https://orcid.org/0000-0003-3845-8079
-
Funding
Funding for this research was provided by:
Sichuan University (ZYYC21005)
- License Information
-
More Information
Article History
Received: 13 November 2023
Revised: 30 April 2024
Accepted: 3 May 2024
First Online: 16 May 2024
Competing interests
: The authors declare no competing interests.
: The conduction of CSAC and CSTC were approved by the ethics committee of West China Hospital, Sichuan University (approval numbers: 2020.469 and 2020.243). The UK Biobank received full ethical approval from the NHS National Research Ethics Service (16/NW/0274). The additional collection of COVID-19 data in those Chinese cohorts and this specific study were approved by the ethics committee of West China Hospital, Sichuan University (2020.469, 2020.243, and 2020.66 [with submitted supplements]). All methods were performed in accordance with the relevant guidelines and regulations.
